Crohn-betegség: vizsgálatok itt: Törökország
10 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Where
- Ankara, Antalya, Bornova, Eskişehir, Istanbul, Kocaeli
- Életkor
- 16 év to 80 év
- People
- 1200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin, Muratpaşa
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Ankara, Istanbul, Kocaeli
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 2/3. fázisTaking peopleA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Ankara, Antalya, Bursa, Istanbul, Izmir, Kocaeli, Mersin
- Életkor
- 18 év and over
- People
- 1092 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00 - 3. fázisTaking peopleA Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Where
- Antalya, Istanbul, Kocaeli, Mersin, Turanköy, ?zmir
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00 - 3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Where
- Ankara, Istanbul, Kocaeli
- Életkor
- 2 év to 17 év
- People
- 110 worldwide
- Run by
- AbbVie
See details and how to joinNCT05995353 · EU 2022-502050-14-00 - 2. fázisTaking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Where
- Ankara, Dilovası, Istanbul, Trabzon
- Életkor
- 18 év to 75 év
- People
- 590 worldwide
- Run by
- AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00 - No phaseTaking peopleEvaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease
- Where
- Sakarya
- Életkor
- 18 év and over
- People
- 100
- Run by
- Sakarya University
See details and how to joinNCT07441447 - No phaseNot yet taking people in TörökországThe Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric Patients
- Where
- Kayseri
- Életkor
- 0 nap to 18 nap
- People
- 500
- Run by
- Sibel Seçkin Pehlivan
See details and how to joinNCT07315711 - No phaseTaking peopleTelehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life
- Where
- Istanbul
- Életkor
- 18 év and over
- People
- 120
- Run by
- Istanbul University - Cerrahpasa
See details and how to joinNCT06971627